CD274 and neoplasm: Programmed death ligand 1 (PD-L1) is a cell surface protein that inhibits the killing function of T cells by interacting with PD-1 receptors on the surface of activated T and B cells and negatively regulates the human immune response, no longer attacking tumor cells [44].